T1D Clinical Trials

53 recruitingLast updated: June 18, 2026

There are 53 actively recruiting t1d clinical trials across 20 countries. Studies span Not Applicable, Phase 2, Phase 1, Early Phase 1, Phase 3. Top locations include Aurora, Colorado, United States, Boston, Massachusetts, United States, Chicago, Illinois, United States. Updated daily from ClinicalTrials.gov.


T1D Trials at a Glance

53 actively recruiting trials for t1d are listed on ClinicalTrialsFinder across 6 cities in 20 countries. The largest study group is Not Applicable with 27 trials, with the heaviest enrollment activity in Aurora, Boston, and Chicago. Lead sponsors running t1d studies include McGill University Health Centre/Research Institute of the McGill University Health Centre, University Hospital, Grenoble, and University of Colorado, Denver.

Browse t1d trials by phase

Treatments under study

About T1D Clinical Trials

Looking for clinical trials for T1D? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new T1D trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about T1D clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 53 trials

Recruiting
Not Applicable

Circadian Mechanisms, Glucose, and CV Risks in T1D

Type 1 Diabetes (T1D)
University of Illinois at Chicago100 enrolled1 locationNCT06624046
Recruiting
Early Phase 1

Simultaneous Measurement and Responsive Treatment - Part 2

Type 1 DiabetesType 1 Diabetes MellitusT1D+1 more
ClinSurge Research40 enrolled1 locationNCT07655076
Recruiting
Not Applicable

DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions

Obesity, OverweightAsthma (Diagnosis)Type 1 Diabetes+3 more
Adhera Health, Inc.280 enrolled1 locationNCT07638345
Recruiting
Not Applicable

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

Diabetes MellitusDiabetes Mellitus, Type 2Diabetes+8 more
University of Colorado, Denver240 enrolled2 locationsNCT07011147
Recruiting
Not Applicable

Pediatric Insulin Plan Calculator for T1DM Management

Type 1 Diabetes Mellitus (T1DM)Type 1 Diabetes MellitusT1DM+1 more
Sultan Qaboos University440 enrolled2 locationsNCT07427134
Recruiting
Phase 1

A Research Study Investigating the Effect of NNC0497-0040 in Healthy Participants, Participants With Overweight or Obesity, and Participants With Type 1 Diabetes With Overweight or Obesity

ObesityHealthy VolunteersOverweight+1 more
Novo Nordisk A/S146 enrolled1 locationNCT07578584
Recruiting
Not Applicable

Type 1 Diabetes REst for Metabolic Health

Type 1 Diabetes (T1D)Sleep Health
University of Colorado, Denver50 enrolled1 locationNCT06627504
Recruiting
Not Applicable

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

Type 1 Diabetes (T1D)Type 2 Diabetes (T2D)
DreaMed Diabetes102 enrolled3 locationsNCT07599982
Recruiting
Phase 2Phase 3

A Clinical Trial Using Tirzepatide to Help Adults With Type 1 Diabetes Automatically Control Their Blood Sugar

Type 1 DiabetesType 1 Diabetes MellitusT1D+2 more
McGill University Health Centre/Research Institute of the McGill University Health Centre105 enrolled4 locationsNCT07284511
Recruiting
Phase 1Phase 2

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

Type 1 DiabetesType 1 Diabetes MellitusType 1 Diabetes Mellitis+7 more
COUR Pharmaceutical Development Company, Inc.72 enrolled30 locationsNCT06783309
Recruiting
Not Applicable

Automated Insulin for Management of Intrapartum Glycemia

PregnancyType 1 Diabetes (T1D)Pre-Gestational Diabetes
University of California, San Francisco150 enrolled2 locationsNCT06883344
Recruiting
Phase 2

A Phase II Study With Exploratory Outcomes of Fucose Supplementation in GLUT1 Deficiency Syndrome

Glut1 DeficiencyGLUT1DS1
Oregon Health and Science University16 enrolled1 locationNCT07432490
Recruiting
Phase 1

A Study of GNTI-122 in Adults Recently Diagnosed With T1D

Type 1 Diabetes MellitusType 1 Diabetes (T1D)
GentiBio, Inc16 enrolled10 locationsNCT06919354
Recruiting

Kidney Precision Medicine Project

Chronic Kidney DiseasesType 1 Diabetes (T1D)Kidney Failure, Acute+12 more
Icahn School of Medicine at Mount Sinai1,000 enrolled13 locationsNCT04334707
Recruiting

Capillary OGTT Study

Type 2 DiabetesType 1 Diabetes (T1D)
University of Oxford135 enrolled4 locationsNCT06815081
Recruiting
Early Phase 1

Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes

T1DM - Type 1 Diabetes Mellitus
Shanghai Zhongshan Hospital9 enrolled1 locationNCT07528105
Recruiting

Study of Glucose Tolerance Abnormalities Using Continuous Glucose Monitoring for the Identification of Early Loss of Pancreatic Islet Graft Function.

Type 1 Diabetes (T1D)
University Hospital, Strasbourg, France36 enrolled1 locationNCT07470593
Recruiting

Type 1 Diabetes Extension Study

Type 1 Diabetes MellitusT1DT1DM
National Institute of Allergy and Infectious Diseases (NIAID)111 enrolled12 locationsNCT02734277
Recruiting
Not Applicable

Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge

Type 1 Diabetes Mellitus (T1DM)Type 2 Diabetes Mellitus (T2DM)Hyperglycemia
Vanderbilt University Medical Center60 enrolled1 locationNCT06852950
Recruiting
Phase 1Phase 2

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

Metabolic DiseaseDiabetes Mellitus, Type 1Type 1 Diabetes+14 more
Otsuka Pharmaceutical Factory, Inc.13 enrolled1 locationNCT06575426